Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex bought the technology platform Pruffme

12/3/24 YDEX

Shareholders of Polyus approved dividends

12/2/24 PLZL

Alfa Bank wants to recover $77.3 mln from Nornickel

12/2/24 GMKN

SMZ's bona fide minority shareholders can expect compensation

12/2/24 MGNZ

China completes construction of the last section of the Siberia Power Grid

12/2/24 GAZP

Shareholders of Sebcement approved dividends

12/2/24 SKCM

Lenta acquires the chain of drogeries Smile of the Rainbow

12/2/24 LENT

Mosgorlombard's revenue grew 4.5 times in January-November

12/2/24 MGKL

Promomed's revenues for 9 months increased by 34%

12/2/24 PRMD

Future Vending has opened a round of investment attraction

12/2/24 OTCI